Gabapentin for Abstinence Initiation in Alcohol Dependence
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Primary Hypotheses:
1. Gabapentin will significantly reduce alcohol consumption and promote abstinence as
compared to placebo. The primary outcome measure will be the number of the heavy drinking
days (defined as any day where the number of standard drinks was at least 5 for men and at
least 4 for women) per week as measured by the timeline follow-back method.
Secondary Hypotheses:
1. Gabapentin will be superior to placebo in reducing alcohol use as measured by percent days
abstinent.